IMUC

ImmunoCellular Therapeutics, Ltd.
IMUC

Delisted

IMUC was delisted on the 16th of October, 2018.

3 hedge funds and large institutions have $5K invested in ImmunoCellular Therapeutics, Ltd. in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
-24
Holders Change %
-88.89%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
Closed
23
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
WS
1
Wedbush Securities
California
$5K +$3.44K +190,000 +220%
Renaissance Technologies
2
Renaissance Technologies
New York
-$254K -1,211,604 Closed
Vanguard Group
3
Vanguard Group
Pennsylvania
-$60K -285,154 Closed
VF
4
Virtu Financial
New York
-$15K -71,027 Closed
Citadel Advisors
5
Citadel Advisors
Florida
-$15K -69,746 Closed
TSS
6
Two Sigma Securities
New York
-$13K -61,448 Closed
UBS Group
7
UBS Group
Switzerland
-$12K -58,540 Closed
FAAS
8
First Allied Advisory Services
California
-$8K -40,000 Closed
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
-$7K -32,871 Closed
Invesco
10
Invesco
Georgia
-$2K -10,992 Closed
NFG
11
Next Financial Group
Texas
-$1K -3,000 Closed
RCAG
12
Rehmann Capital Advisory Group
Michigan
-$14 -69 Closed
APA
13
American Portfolios Advisors
New York
-$1 -5 Closed